The global Non-Steroidal Anti-Inflammatory Drugs Market (NSAIDs) market is a substantial and dynamic sector within the pharmaceutical industry. These medications are widely used to alleviate pain, reduce inflammation, and control fever.

The non-steroidal anti-inflammatory drugs market is estimated to be valued at USD 25.84 Bn in 2025 and is expected to reach USD 38.60 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

Key Takeaways

The major players operating in the non-steroidal anti-inflammatory drugs market include

·         Pfizer Inc.,

·         Johnson & Johnson Services, Inc.,

·         Bayer AG, Sanofi, GSK plc,

·         Heron Therapeutics, Inc.,

·         Strides Pharma Science Limited,

·         Sun Pharmaceutical Industries Ltd.,

·         Reckitt Benckiser Group PLC,

·         Assertio Holdings, Inc.

Market Size and Growth:

The NSAIDs market has experienced steady growth over the past few years and is projected to continue expanding in the coming years. Factors such as the rising prevalence of chronic diseases, the increasing geriatric population, and growing demand for over-the-counter medications contribute to this growth.

       Get More Insight On : Epstein-Barr Virus (EBV) Market

Get this Report in Japanese Language: 非ステロイド性抗炎症薬市場

Get this Report in Korean Language: 비스테로이드성항염제시장